We’ve all experienced pain in our lives of course, but what of those who have chronic pain. Whether due to rheumatoid arthritis, fibromyalgia, migraines even multiple sclerosis, living with the effects of these debilitating conditions day in and day out can certainly take its toll. Doctors have historically prescribed everything from common analgesics like ibuprofen to heavier duty drugs such as Humira and Enbrel. As with so many modern day pharmaceuticals however, they generally come with side effects that can be harmful.
CBD for the treatment of pain is becoming more and more common place as people are experiencing the benefits of cannabidiol firsthand. Natural pain relief versus medications that could potentially damage your liver—seems like a no-brainer.
Rheumatoid Arthritis (RA)
Those that live with this chronic condition understand the agony, they know how terribly restrictive stiff and inflamed joints can be, and they simply want relief from the excruciating ache of RA. Generally affecting those 35 or older, RA has traditionally been addressed through the use of powerful drugs, some of which are often advertised to contain discomforting side effects.
A 2006 study in fact showed that not only did CBD seem to effect pain mitigation, the study also mentioned other aspects of CBD as well.
Fibromyalgia is generally characterized by chronic pain, tenderness in certain areas, and the accompanying anxiety that can result from these things. To date, Fibromyalgia treatments have consisted of opioids and certain steroids—all with unwanted side effects.
So many people worldwide suffer from migraines. A debilitating form of headache can be accompanied by nausea among other issues. Therefore, those who regularly experience this type of headaches tend to be of the mindset that they just “have to live with it.” But what about CBD for migraines?
Exploring your options when it comes to various forms of chronic pain treatment may help you find something that works for you. CBD tinctures are rapidly becoming a popular choice among consumers who want a measured amount of cannabinoids.